Author
![]() |
VEGA-LOPEZ, SONIA - TUFTS-HNRCA |
![]() |
YEUM, KYUNG-JIN - TUFTS-HNRCA |
![]() |
LECKER, JAIME - TUFTS-HNRCA |
![]() |
AUSMAN, LYNNE - TUFTS-HNRCA |
![]() |
JOHNSON, ELIZABETH - TUFTS-HNRCA |
![]() |
DEVARAJ, SRIDEVI - UC DAVIS MEDICAL CENTER |
![]() |
JIALAL, ISHWARLAL - UC DAVIS MEDICAL CENTER |
![]() |
LICHTENSTEIN, ALICE - TUFTS-HNRCA |
|
Submitted to: The American Journal of Clinical Nutrition
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 9/3/2004 Publication Date: 1/1/2005 Citation: Vega-Lopez, S., Yeum, K., Lecker, J.L., Ausman, L.M., Johnson, E.J., Devaraj, S., Jialal, I., Lichtenstein, A.H., 2005. Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. American Journal of Clinical Nutrition. 81(1):43-49. Interpretive Summary: Several studies have suggested that one of the beneficial properties of soybeans relies on its ability to reduce propensity to oxidation. Among the components of soybeans, isoflavones have been shown to work as antioxidants in laboratory tests, but results from human studies in which participants took supplements containing soy isoflavones are inconclusive. In addition, whether the protein found in soy has antioxidant properties had not been previously tested. This study was designed to evaluate the independent antioxidant effects of the protein and isoflavone components of soy. Forty-two participants over 50 y with high cholesterol participated in the study. Volunteers consumed each of the following diets: soy protein without isoflavones, soy protein with isoflavones, animal protein without isoflavones, animal protein with added soy-isoflavones. We measured the antioxidant activity of the blood and the susceptibility of oxidation of blood components at the end of each phase. After consumption of the soy containing diets the blood of participants had higher antioxidant activity. However, when diets contained isoflavones, the fat components of the blood were more easily oxidizable. While soy protein was associated with a modest improvement in antioxidant activity, soy isoflavones were not, which may explain the discrepancies in previous studies, given that different studies have used a wide variety of products containing different amounts of soy protein and isoflavones. Technical Abstract: Several clinical trials have suggested that soy intake decreases oxidative stress. Soy isoflavones have antioxidant properties in vitro, but results from supplementation clinical trials are inconclusive. The objective was to evaluate the independent effects of soy protein and soy-derived isoflavones on plasma antioxidant capacity and biomarkers of oxidative stress. Forty-two hypercholesterolemic (LDL-cholesterol>3.36 mmol/L) subjects aged >50 y were provided with each of 4 diets in random order in a crossover design. Diets varied in protein source (10% energy, soy or animal) and isoflavone content (trace or 50 mg/1000 Kcal) and were consumed for 42 days each. Plasma antioxidants, protein carbonyls, malondialdehyde, total antioxidant performance, LDL oxidizability and urinary F2-isoprostanes were measured at the end of each dietary phase. Plasma antioxidants concentrations were not significantly different, regardless of dietary treatment, except for isoflavones, which were higher after isoflavone supplementation (P=0.0001). Although plasma total antioxidant performance was 10% higher with soy protein intake, regardless of dietary isoflavones (P=0.0003), soy protein did not significantly affect most individual markers of oxidative stress (LDL oxidizability, urinary F2-isoprostanes, malondialdehyde or protein carbonyls in native plasma). However, soy protein was associated with modestly lower concentration of protein carbonyls in oxidized plasma. There was no significant effect of isoflavones on LDL oxidation, urinary F2-isoprostanes or protein carbonyl groups, although, paradoxically, plasma malondialdehyde concentration was significantly higher after the isoflavones-rich diets (P=0.04). Diets relatively high in soy protein or soy-derived isoflavones have little effect on plasma antioxidant capacity and biomarkers of oxidative stress. |
